Oncology

Chronic obstructive pulmonary disease (COPD), a leading cause of mortality worldwide, is characterized by chronic bronchitis and emphysema.1…

A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune…

Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…

After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in…

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and…

CEO Joaquin Duato presented a strong outlook for Johnson & Johnson’s (J&J) revenue growth in 2026, with particular…

Credit: Md Saiful Islam Khan / iStock / Getty Images Plus Scientists across six leading U.S. institutions have…

KUALA LUMPUR, Dec 22 — Prostate cancer remains one of the most misunderstood cancers among Malaysian men, despite…

Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…

Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease